TrialHuman vaccines & immunotherapeutics2026

Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial.

Andrew Hastie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.